创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the main advantages of the MHC humanized mouse model?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-11 15:18
  • Views:

(Summary description)With the deepening of biomedical research, there is an increasing need for scientists to study the occurrence, development and treatment strategies of diseases. In this process, animal models play an irreplaceable role as important experimental tools. Among them, InnoModels Biotechnology MHC humanized mouse model has become a star model in the field of biomedical research with its unique advantages

InnoModels Biotechnology: What are the main advantages of the MHC humanized mouse model?

(Summary description)With the deepening of biomedical research, there is an increasing need for scientists to study the occurrence, development and treatment strategies of diseases. In this process, animal models play an irreplaceable role as important experimental tools. Among them, InnoModels Biotechnology MHC humanized mouse model has become a star model in the field of biomedical research with its unique advantages

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-11 15:18
  • Views:
Information

With the deepening of biomedical research, there is an increasing need for scientists to study the occurrence, development and treatment strategies of diseases. In this process, animal models play an irreplaceable role as important experimental tools. Among them, InnoModels Biotechnology MHC humanized mouse model has become a star model in the field of biomedical research with its unique advantages.
The main advantages of MHC humanized mouse model are reflected in the following aspects:
1. Closer simulation of the human immune system
The MHC humanized mouse model is closer to the human immune system through the successful implantation of the human MHC system, which is a key group of genes controlling the body's immune response and is closely related to the function of the immune system. Therefore, the model can better simulate the human immune response and provide more accurate data for drug development.
2、Provide an ideal tool for immunotherapy research
The MHC humanized mouse model provides an ideal tool for immunotherapy research. Scientists can use the model to more comprehensively assess the effects of immunotherapy in vivo, and thus more accurately predict the efficacy of immunotherapy in humans. This is important for the development of novel therapeutic strategies and provides strong support for the advancement of clinical applications.

 


3. Breakthroughs in cancer immunotherapy
The MHC humanized mouse model has great potential in cancer immunotherapy research. By mimicking the response of the human immune system, researchers can better understand how tumors respond to immunotherapy, thus providing important clues for personalized treatment. For example, scientists can use the model to screen the most effective immunotherapy regimen for a specific tumor type, enabling individualized treatment and improving the survival rate and quality of life of cancer patients.
In conclusion, the InnoModels Biotechnology MHC humanized mouse model has become a popular model in the field of biomedical research due to its key advantages, such as closer simulation of the human immune system, providing an ideal tool for immunotherapy research, and breakthroughs in cancer immunotherapy. As the model continues to be optimized and improved, it is believed that it will play a greater role in disease research and development of therapeutic strategies in the future, and make greater contributions to human health.   

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司